Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030

  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 63%

News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.

In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drug maker believes it can almost double revenues by the end of the decade.

AstraZeneca announced in late May it plans to raise revenues from $45.8 billion in 2023 to $80.billion in 2030, as well as release 20 new drugs by then."Biology is complicated, and we're never sure of anything. But we have a great level of confidence we can get there, and I think this target forces us to think creatively and be ambitious and stretch," Soriot said."But we have a large portfolio of existing products, several blockbusters...

The company recently released promising results about several of its cancer drugs at the American Society of Clinical Oncology's annual meeting, including ones for lung and breast cancers.Cramer's Lightning Round: SoundHound is a sell "Science has exploded in the last ten, fifteen years, and what you see happen at the ASCO gives you hope that the day when cancer can be cured is not that far away," he said."Either cured or turned to a chronic condition."news

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 270. in UK
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030AstraZeneca CEO Pascal Soriot discussed his company’s ambitious revenue goal with CNBC’s Jim Cramer.
Source: NBCLA - 🏆 319. / 59 Read more »